CELYAD ONCOLOGY NPV revenue for the last year amounted to 102.00 k EUR, the most of which — 102.00 k EUR — came from its highest performing source at the moment, Cardiology, the year earlier bringing 5.00 k EUR. The greatest contribution to the revenue figure was made by Europe and United States — last year it brought CELYAD ONCOLOGY NPV 102.00 k EUR, and the year before that — 5.00 k EUR.